|
Upon receipt, the device interrogation revealed the battery status eri, 19 charging cycles were recorded to the device memory.The icd was subjected to an electrical analysis.The ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.A fibrillation signal was applied and the device detected the fibrillation signal as specified and started the charging of a defibrillation shock.However, the charging of a 40 joule shock was aborted as a result of a depleted battery.The current consumption of the icd was analyzed and found to be normal and as expected.However, the data showed an inconsistency between the amount of charge taken from the battery and the battery voltage.Therefore, the device was opened.The measurement of the battery voltage confirmed a depleted battery.The electronic module was attached to an external power supply to check the functionality of the electronic module.There was no indication of a malfunction, particularly all therapy functions were available and worked as expected.The battery was sent to the manufacturer for further analysis.The manufacturing records of the battery were inspected, documenting that the battery parameters were within specification during the battery manufacturing.No anomalies were documented during the production process, associated to this battery.The battery was subjected to a visual and an electrical inspection as well as a microcalorimetry analysis.The visual inspection of the battery did not reveal any external signs of damage.The microcalorimetry analysis showed an elevated heat dissipation.Next, the battery was opened for destructive analysis.During the inspection of the inner assembly an insulation damage within the battery was identified, which led to the elevated internal self-depletion.In conclusion, an increased internal self-depletion within the battery was found to be the root cause for the clinical observation.
|